Page last updated: 2024-11-08

biguanides and Erythema Multiforme

biguanides has been researched along with Erythema Multiforme in 2 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Erythema Multiforme: A skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic bull's-eye lesions usually occurring on the dorsal aspect of the hands and forearms.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gehanno, JF1
Priot, AE1
Balguerie, X1
Caillard, JF1
Almeyda, J1
Baker, H1

Reviews

1 review available for biguanides and Erythema Multiforme

ArticleYear
Drug reactions. X. Adverse cutaneous reactions to hypoglycaemic agents.
    The British journal of dermatology, 1970, Volume: 82, Issue:6

    Topics: Antigens; Biguanides; Desensitization, Immunologic; Drug Eruptions; Drug Hypersensitivity; Erythema

1970

Other Studies

1 other study available for biguanides and Erythema Multiforme

ArticleYear
Polyhexamethylenebiguanide hydrochloride exposure and erythema multiforme in a physician.
    International journal of occupational medicine and environmental health, 2006, Volume: 19, Issue:1

    Topics: Biguanides; Erythema Multiforme; Female; France; Humans; Middle Aged; Occupational Exposure; Physici

2006